Search

Your search keyword '"Ghezzi, Angelo"' showing total 343 results

Search Constraints

Start Over You searched for: Author "Ghezzi, Angelo" Remove constraint Author: "Ghezzi, Angelo" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
343 results on '"Ghezzi, Angelo"'

Search Results

4. Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study

5. Long-term Cognitive Outcomes and Socioprofessional Attainment in People With Multiple Sclerosis With Childhood Onset

8. Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting

10. The Italian multiple sclerosis register

17. Neurofilament Light Chain in Adult and Pediatric Multiple Sclerosis:A Promising Biomarker to Better Characterize Disease Activity and Personalize MS Treatment

18. Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)

19. A Comprehensive Review on Copemyl®

22. Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks

23. Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks

27. Correction to: The Italian multiple sclerosis register

28. Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 years

29. Effect of fingolimod on health-related quality of life in paediatric patients with multiple sclerosis: results from the phase 3 PARADIGMS Study

31. Etiological research in pediatric multiple sclerosis: A tool to assess environmental exposures (PEQ-IT)

32. Etiological research in pediatric multiple sclerosis: A tool to assess environmental exposures (PEDiatric Italian Genetic and enviRonment ExposurE Questionnaire)

33. Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis

34. Pregnancy in multiple sclerosis women with relapses in the year before conception increases the risk of long-term disability worsening

35. sj-docx-1-mso-10.1177_20552173211059048 - Supplemental material for Etiological research in pediatric multiple sclerosis: A tool to assess environmental exposures (PEDiatric Italian Genetic and enviRonment ExposurE Questionnaire)

36. sj-docx-2-mso-10.1177_20552173211059048 - Supplemental material for Etiological research in pediatric multiple sclerosis: A tool to assess environmental exposures (PEDiatric Italian Genetic and enviRonment ExposurE Questionnaire)

37. The introduction of new medications in pediatric multiple sclerosis:Open issues and challenges

38. Risk of Persistent Disability in Patients With Pediatric-Onset Multiple Sclerosis

39. Identifying distinct cognitive phenotypes in multiple sclerosis (4284)

40. Identifying the Distinct Cognitive Phenotypes in Multiple Sclerosis

42. Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS : Practical considerations

43. Pregnancy in multiple sclerosis women with relapses in the year before conception increases the risk of long-term disability worsening.

45. Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis

46. Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy in paediatric patients with multiple sclerosis: Results from the PARADIGMS study

47. Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerations

48. The introduction of new medications in pediatric multiple sclerosis: Open issues and challenges

49. Changes in Management of Pediatric-onset Multiple Sclerosis: Are We Really Modifying the Disease Course? Data from the Italian MS Registry (3938)

50. Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study

Catalog

Books, media, physical & digital resources